﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>prasugrel news stories on Newser</title><description>Read more prasugrel stories on Newser</description><link>http://www.newser.com/taggrid/16389/prasugrel.html</link><image><url>http://img1-cdn.newser.com/images/newser-black250x40.gif</url><title>prasugrel news stories on Newser</title><link>http://www.newser.com/</link></image><copyright>2012 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Wed, 23 May 2012 06:46:47 CDT</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/50598/novartis-acquires-plavix-rival.html</guid><title>Novartis Acquires Plavix Rival</title><dc:creator>Jim O'Neill</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=181149&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110331232626' border='0' /&gt;Novartis AG will pay a San Francisco biopharmaceutical company $75 million—with the potential for an additional $500 million—for the worldwide rights to an experimental anticlotting drug the Swiss drug firm hopes will rival Plavix, reports the Wall Street Journal. Market leader Plavix rang up $8.22 billion in...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=181149&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110331232626" type="image/jpg" medium="image"><media:description type="plain">Plastic bottles of Plavix lie on a shelf in Ballin Pharmacy in Chicago, Illinois.</media:description></media:content><link>http://www.newser.com/story/50598/novartis-acquires-plavix-rival.html</link><pubDate>Thu, 12 Feb 2009 08:22:53 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/10974/new-blood-thinner-tops-plavix-in-trials.html</guid><title>New Blood Thinner Tops Plavix in Trials</title><dc:creator>Kevin Spak</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=42489&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401030231' border='0' /&gt;An experimental new blood-thinner looks like real competition for top-selling anti-clotting drug Plavix, after proving more effective at preventing heart attacks, strokes, and heart-related death in a recent trial, the AP reports. But “there is a price to pay” for increased effectiveness, wrote one doctor—the new drug caused an...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=42489&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401030231" type="image/jpg" medium="image"><media:description type="plain">Blood thinner medication Plavix is shown July 28, 2006 in a New York file photo. (AP Photo/Mark Lennihan, File)</media:description></media:content><link>http://www.newser.com/story/10974/new-blood-thinner-tops-plavix-in-trials.html</link><pubDate>Mon, 05 Nov 2007 09:00:41 CST</pubDate></item></channel></rss>
